Why is ERIS Lifescience falling/rising?

As of 23-Jun, ERIS Lifesciences Ltd is experiencing a decline in its stock price, currently at Rs 1,620.00, which reflects a decrease of Rs 4.1 or 0.25%. The stock has been on a downward trend for the past five days, with a significant drop of 12.72% during this period. Today's trading saw the stock hit an intraday low of Rs 1,579.4, indicating a loss of 2.75%. Despite this recent decline, the stock has shown strong performance over the longer term, with a year-to-date increase of 18.34% and a remarkable 55.59% rise over the past year. Positive factors contributing to the stock's appeal include high management efficiency, strong debt servicing capability, and significant institutional holdings. However, concerns about poor long-term growth and an expensive valuation relative to its peers may be weighing on investor sentiment.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark, as the Sensex has only increased by 0.12% over the past week. This underperformance relative to the benchmark may be influencing investor perceptions and contributing to the stock's decline. While ERIS Lifesciences has outperformed the BSE 500 over the long term, the recent negative returns and the stock's consecutive falls could be prompting caution among investors, particularly in light of the company's declining profits despite its strong historical returns.